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DNA of a new papillomavirus type was cloned from a cer-
vical carcinoma biopsy. Two EcoRI clones of 7.8 and 6.9 kb
in length were obtained, the latter contained a 900-bp dele-
tion. The BamHI fragments of both clones were used to
characterize the DNA. It represents a distinct type of papil-
lomaviruse as determined by its size, its cross-hybridization
with DNA of other papillomavirus types under conditions of
low stringency only, the co-linear alignment of its genome
with HPV 6 and HPV 16 prototypes and its occasional occur-
rence as oligomeric episomes. We tentatively propose to
designate it as HPV 18. DNA hybridizing with HPV 18 under
stringent conditions was detected in 9/36 cervical carcinomas
from Africa and Brazil, in 2/13 cervical tumors from Ger-
many and 1/10 penile carcinomas. Benign tumors (17 cervical
dysplasias, 29 genital warts), eight carcinomata in situ and 15
biopsies of normal cervical tissue were devoid of detectable
HPV 18 DNA. HPV 18-related DNA was found, however, in
cells of the HeLa, KB and C4-1 lines all derived from cervical
cancer. The state of the viral DNA was investigated in four
cervical cancer biopsies. The data reveal that the DNA might
be integrated into the host cell genome. One tumor provided
evidence for head to tail tandem repeats some of which per-
sisted as circular episomes.
Key words: human papillomaviruses/genital cancer/molecu-
lar cloning/genome integration
Introduction
Papillomaviruses are known to cause benign proliferations of
skin and mucosa revealing the characteristic histological pat-
tern of papillomas or fibropapillomas (for reviews, see
Rowson and Mahy, 1967; zur Hausen, 1977). This group of
viruses is remarkably heterogeneous and at least 25 distinct
genotypes have been identified in man (reviewed by Gissmann
and Schwarz, 1984). For many of these types a specific pat-
tern of induced macroscopic and microscopic lesions has been
established (Orth et al., 1981).
More recently, evidence has accumulated that certain types
of human paillomaviruses (HPV) are closely associated with
specific human cancer. In different laboratories the presence
of HVP 5 and 8 in cancerous tissues of squamous cell car-
cinomas arising in patients with epidermodysplasia ver-
ruciformis has been demonstrated (Orth et al., 1980; Ostrow
et al., 1982; Pfister et al., 1983; G. Orth, personal com-
munication). The suspected role of papillomaviruses in
human genital cancer (zur Hausen, 1976) received substantial
support by recent findings: HPV 6 DNA was demonstrated in
non-metastasizing verrucous carcinomas (Buschke-Lowen-
stein tumors) of the penis and vulva (Gissmann et al., 1982a).
In a few biopsies from patients with cervical cancer HPV 10
(Green et al., 1982) or HPV 11 (Gissmann et al., 1983) DNA
was demonstrated. Very recently a HPV DNA cloned directly
from a cervical cancer biopsy, designated as HPV 16, was
demonstrated in a high percentage of cervical, vulval and
penile cancer biopsies (Durst et al., 1983) as well as in clearly
precancerous lesions, such as Bowen's disease and Bowenoid
papulosis (Ikenberg et al., 1983).
The present report describes the isolation and partial
characterization of a new type of HPV DNA isolated from a
cervical cancer biopsy. It also analyzes the presence of this
DNA in additional cancer biopsies as well as in cell lines
derived from cervical cancer.
Results
Cloning ofa new type ofhuman papillomavirus DNA from a
cervical carcinoma biopsy
A large number of cervical carcinoma biopsies obtained from
various geographic regions was screened for the presence of
HPV 8, 9, 10 and 11-related sequences by low stringency
hybridization. By southern blotting, DNA from one tumor
from a Brazilian patient (WV-341) revealed after EcoRI
digestion two bands (7.8 and 6.9 kb), after BamHI cleavage
three bands (16, 6.7 and 5.8 kb), (Figure 1). After washing
the filters at conditions of higher stringency (Tm - 30°C or
Tm - 18°C, respectively), the 16-kb and subsequently the 6.7-
and 5.8-kb fragments were no longer detectable (Figure 1).
A genomic library was constructed from the BamHI-
restricted tumor DNA using X L 47 as vector. Screening with
a radioactive mixture of HPV 8, 9, 10 and 11 DNA under
non-stringent conditions revealed a number of recombinant
phages containing either the 6.7-kb or the 5.8-kb BamHI
fragments (K51 and K50 shown in Figure 2, lanes a). Both of
these sequences were present within the tumor DNA at high
copy number (-50-100 copies per diploid cell). They are
closely related to each other as shown by cross-hybridization
under stringent conditions (Figure 2). No hybridization was
noted with DNA from human embryonic fibroblasts (Figure
2, lane c) even at a sensitivity permitting the detection of less
than one genome equivalent or at conditions of low stringen-
cy (data not shown).
The 16-kb BamHI fragment, detected in the original tumor
under conditions of low stringency of hybridization, did not
hybridize with one of the cloned fragments even at low str-
ingency. Thus, it appears to be an entirely unrelated sequence
which has not yet been further characterized. Cleavage maps
constructed for the 6.7- and 5.8-kb fragments revealed the
identity of both fragments except for a deletion of - 900 bp
in the smaller fragment (Figure 3). Mapping of this deletion
was possible within + 180 bp (see legend of Figure 3).
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Fig. 1. Blot hybridization at low stringency conditions using a 32P-labelled
mix of HPV 8, 9, 10 and 11 with WV 341-tumor DNA restricted with
EcoRI (lanes E) or BamHI (lanes B). The filter was washed at 40°C below
melting temperature (Tm) of DNA (left) and re-washed at 30°C below Tm
after the first exposure (middle) and again re-washed at 18°C below Tm
(right). Exposure times, corrected for 32P-decay, were 10 times longer for
the second and third exposure in order to clearly demonstrate the disap-
pearance of bands. Length marker is X DNA cleaved with HindIII
(23 696 bp, 9636 bp, 6636 bp, 4333 bp, 2257 bp, 1985 bp, 561 bp).
After cleaving the cellular DNA of WV-341 with EcoRI
and annealing it under stringent conditions with the cloned
BamHI 6.7-kb fragment, two bands of 7.8 and 6.0 kb in size
were detected. Both sequences were molecularly cloned and
characterized. A comparative restriction enzyme analysis
revealed that the 7.8-kb sequence encompasses the 6.7-kb
probe, whereas the 6.9-kb sequence contains the deletion of
900 bp (Figure 3).
In subsequent experiments, unless indicated, the 6.7-kb
BamHI fragment was used as probe. Hybridization of this
DNA with cloned DNA derived from other human papillo-
mavirus types under conditions of low stringency revealed
some relatedness with HPV 1-6 and HPV 8-17 which was
slightly more pronounced with HPV types 2, 3, 6, 10, 11, 13
and 16. A small degree of homology was discernible after
hybridization with HPV 2 DNA even under stringent condi-
tions (data not shown). The new DNA is tentatively
designated as HPV 18.
A co-linear arrangement of the HPV 6b genome (de
Villiers et al., 1981; Schwarz et al., 1983) and the BamHI
fragment of the new isolate, representing 860%o of the genome,
was demonstrated by annealing purified subgenomic
fragments under conditions of low stringency (Figure 4). In
addition, co-linearity of HPV 18 DNA with the HPV 16
genome could also be demonstrated (data not shown).
Fig. 2. Blot hybridization at high stringency conditions with two fragments
(K50 and K51) cloned from a cervical carcinoma (WV 341). 10 ,ug of total
cellular DNA from the tumor biopsy (WV 341) were cleaved with BamHI
and electrophoresed in a 0.7% agarose gel (lanes a). 10 Ag of DNA
extracted from human embryonic lung fibroblasts (HEL) were cleaved with
BamHI and used as control (lanes c). Reconstructions of 10 genome
equivalents are shown in lanes b (100 pg of the respective cloned fragment
mixed with 10 yg of BamHI restricted HEL-DNA as carrier). The 5.8-kb
BamHI fragment (K50, left side) and the 6.7-kb BamHl fragment (KS1,
right side) purified from the phage vector were used as probes.
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Fig. 3. Physical map of HPV 18 linearized with BamHl. The cloned
fragments K50 (5.8 kb) and K51 (6.9 kb), as indicated, were mapped by
analyzing double digests and partial digests. The map was then completed
and confirmed by cleavage of WV 341 tumor DNA with the same set of
restriction enzymes and subsequent blot hybridization with 32P-labelled
K51. There might be additional FnuDI or Sau3A cleavage sites within the
HPV 18 portion (dashed line) not covered by the probe used in this experi-
ment (K51). The closed box represents the 900-bp deletion distinguishing
K50 from K51. Non-cut enzymes are: Bglll, HindlII, SaiI, SstI, XhoI.
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Fig. 4. Co-linearity between HPV 18 and HPV 6b. The 86%1o BamHI fragment of HPV 18 was cleaved with HincIl, TaqI and HpaII. The triple digest was
separated on a preparative gel and the four largest fragments were recovered. HPV 6b was cut off from the vector with BamHI and a double digest with Ac-
cI and HpaI was subjected to Southern blotting and hybridization under non-stringent conditions with the purified HPV 18 fragments as probes. Cross-
hybridization between fragments of HPV 6b and HPV 18 is indicated. Dashed lines represent weak hybridization. The dashed line in the HPV 18 map
represents the small BamHI fragment of HPV 18 not used in this experiment. The 900-bp deleteion is indicated by a filled box.
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Fig. 5. Detection of HPV 18 sequences in cervical carcinomas. (A) WV 853
from Uganda, (B) WV 1445 from Kenya, (C) WV 1547 from Uganda,
(D) WV 1660 from Kenya, (E) WV 858 from Uganda, (F) WV 1443 from
Kenya. Total cellular DNA was cleaved with BamHI (A, C, D, F) or
EcoRI (B, E), electrophoresed in 1% agarose gels and blot hybridized
under low stringency conditions (Tm - 40°C) with 32P-labelled 86'1o HPV
18 fragments (left lanes). Filters were then re-washed at stringent conditions
(Tm - 18°C) and re-exposed for exactly the same time (right lanes). A- D
contain HPV 18 sequences, whereas E and F harbor related papillomavirus
sequences as indicated by the absence of hybridization at high stringency
conditions. For mol. wt. of the length markers see Figure 1.
HPV 18 sequences in tumor biopsy material
A number of cervical carcinoma biopsies as well as benign
genital tumors and normal cervical tissue were examined by
Southern blot analysis for the presence of HPV 18 DNA.
Hybridization at low stringency followed by subsequent
washing at high stringency after the first exposure (Durst et
al., 1983) permitted the detection of HPV 18-specific as well
as that of related sequences within the same experiment
(Figure 5). As shown in Table I, DNA from nine out of 36
cervical carcinomas originating from Africa or Brazil reacted
with HPV 18 DNA under stringent conditions. DNA from
five additional tumors was positive at conditions of low str-
ingency only. Two out of 13 cervical carcinomas from Ger-
man patients reacted with HPV 18 DNA under stringent con-
ditions. Cervical carcinomata in situ, dysplasias as well as
seven biopsies from vulval cancer were negative for HPV 18
DNA. One penile carcinoma obtained from a Brazilian pa-
tient was particularly interesting, since it represents the only
sample thus far identified containing simultaneously HPV 18
and HPV 16 sequences.
Twenty-nine biopsies from genital warts (condylomata
acuminata), including five samples from African patients, as
well as 15 samples from clinically inconspicuous cervical
tissue were negative for HPV 18 DNA.
HPV 18 sequences in established cell lines
DNA obtained from three cell lines (HeLa, KB and C4-1) was
tested for the presence of HPV 18 DNA. These lines contain
sequences hybridizing with HPV 18 DNA under stringent
conditions (Figure 6). It is interesting to note that the size of
the hybridizing fragments after digestion with various restric-
tion enzymes is identical in HeLa and KB cells (faint addi-
tional bands are seen in KB DNA) supporting earlier observa-
tions revealing the HeLa origin of KB cells (Nelson-Rees and
Flandermeyer, 1976). HeLa and C4-1 lines have been
established from cervical cancer biopsies. Evidence indicative
of a covalent integration of the HPV 18-related DNA into the
genome of these cells will be presented elsewhere.
Physical state ofHPV 18 DNA in cervical tumors
By digesting WV-341 DNA with six different non-cut en-
zymes for HPV 18 DNA no discrete bands were discernible in
Southern blots after hybridization with HPV 18 DNA (Figure
7). At - 20 kb some hybridization was visible smearing over
a substantial region of the gel. If enzymes cutting HPV 18
DNA once (EcoRI) or several times (BamHI, XbaI) were us-
ed, however, hybridization in the high mol. wt. region disap-
peared and discrete bands became visible. To rule out non-
specific trapping of viral sequences, WV-341 DNA was
digested simultaneously with all six non-cut enzymes. This
resulted in substantial degradation of cellular DNA as seen
after ethidium bromide staining. HPV 18 DNA still hybridiz-
ed in the high mol. wt. region (data not shown).
Two-dimensional agarose gel electrophoresis according to
Wettstein and Stevens (1982) was used to separate circular
DNA (nicked and supercoiled) from linear DNA in the high
molecular smear of viral DNA shown in Figure 7. As shown
in Figure 8, the majority of HPV 18-specific sequences co-
migrated with linear DNA as evidenced by superimposition to
the trail of cellular DNA stained with ethidium bromide. A
minor fraction was resolved as separate spots migrating
slower in the second dimension, thus apparently representing
circular viral DNA molecules. The two spots with the lowest
mol. wt. seen in Figure 8 may represent supercoiled dimers of
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Table I. Occurrence of HPV 18 DNA in genital tumors
Diagnosis Geographic origin Biopsies positive for HPV 18 DNA Total of HPV-
Stringent Non-stringent positive biopsiesb
conditions conditions only'
Cervical carcinoma Germany 2/13 (15.4%) 0/13 11/13 (84.6%)
Cervical carcinoma Kenya, Uganda 9/36 (25%) 5/36 (13.907) 30/36 (83.3%)
Brazil
Cervical carcinoma in situ Germany 0/8 0/8 5/8 (62.5%)
Cervical dysplasia Germany 0/17 0/17 10/17 (58.8%)
Vulval carcinoma Germany (n = 6) 0/7 0/7 3/7 (42.9%)
Africa (n = 1)
Penile carcinoma Germany (n = 5) lc/10 0/10 3/10 (30%)
Africa, South
America (n =5)
Condyloma acuminatum Germany (n =24) 0/29 n.t.d 28/29 (96.5%)
Africa (n =5)
Normal cervical tissue Germany 0/15 0/15 0/15 (0%)
aAM biopsies revealing the same fragment pattern as with HPV 16 under stringent conditions were not counted as positives, since HPV 18 and HPV 16 cross-
hybridize under non-stringent conditions.bpositive under non-stringent or stringent conditions with 32P-labelled HPV 6, 10, 16, 18, respectively, data taken from lkenberg et al., in preparation.
cCnan HPV 16 and HPV 18 sequences.
dNot tested.
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Fig. 6. Blot hybridization of cellular DNA extrtacted from KB (1) or HeLa
cells (2) after cleavage with HindIII (a), EcoRI (b) and BamHl (c) with
32p-labelled HPV 18 DNA (EcoRI clone, representing the complete
genome) under stringent conditions. 10 pg of the 5.8-kb BamHl fragment
(K50) of HPV 18 were included as sensitivity marker.
Fig. 7. Blot hybridization of WV 341 DNA with the 86% HPV 18
fragment under stringent conditions. 2 jig of DNA were digested with the
enzyme indicated on top of each lane and separated on a 0.4% agarose
gel. For mol. wt. of the length markers see Figure 1.
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Fig. 8. Analysis of HPV 18 DNA by two-dimensional gel electrophoresis.
WV 341 tumor DNA (10 itg) was double digested with two non-cut
enzymes (XhoI and Sall) and electrophoresed in 0.407o agarose (first
dimension) and 1 0/o agarose (second dimension). A Southern blot was then
prepared and hybridized with the 860%o HPV 18 fragment. Circular
oligomeric molecules are visible as separate distinct spots. For mol. wt. of
the length markers see Figure 1.
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Fig. 9. Partial digestion of WVV 341 DNA with EcoRI. The reaction was
started with 20 tig DNA and U/ttg EcoRI. 2 ~tg aliquots were taken at
the times indicated on top of each lane. Reaction was stopped immediately
by adding EDTA to 25 mM and chilling on ice. Pre-digestion with a non-
cut enzyme (Sstl) was performed in order to obtain good separation on a
0.4% gel. Linear dimers (-- 15 kb) and trimers (-22 kb) are indicated by
arrows. For mol. wt. of the length markers see Figure 1.
Flg. 10. Blot hybridization under stringent conditions of DNA from the
cervical carcinoma WV 1661 with 32P-labelled 86%o HPV 18 fragment.
Total cellular DNA was digested with the restriction enzymes indicated on
top of each lane and separated on a 0.4% agarose gel. The BgIII digest
was run in a second dimension into l1o agarose (left side). No circular
molecules could be detected. The 86% HPV 18 fragment (6.7 kb) was run
in parallel (lane V). For mol. wt. of the length markers see Figure 1.
HPV 18 (7.8 kb) and of the deleted molecules (6.9 kb),
respectively, as calculated from the mobility of circular
marker DNAs (not shown). No monomeric forms of HPV 18
DNA were detected.
After digestion with single or multi-cut restriction enzymes
the same fragments as expected from the physical map (see
Figure 3) were demonstrated within the tumor. Since this
DNA contains a high copy number of viral genome equiv-
alents, the presence of viral DNA in head-to-tail tandem
repeats is suggesed. The demonstration of linear dimers and
trimers after partial digestion of tumor DNA (Figure 9) pro-
vides direct evidence for tandem repetition. A number of sub-
molar bands are visible in Figure 9 migrating faster than unit-
length viral DNA. They did not change in mobility when
WV-341 was digested with EcoRI in combination with non-
cut enzymes. Thus, although very likely, no direct evidence is
available for an integration of viral DNA into the host cell
genome of this tumor. In three additional HPV 18-positive
tumors, however, cleavage with single as well as with multi-
cut enzymes provided patterns different for all tumor DNAs.
Discrete bands were also obtained after cleavage with non-cut
enzymes for one of these tumors (Figure 10). Since the
cleavage pattern varied by using different non-cut enzymes
and since most of the bands migrated slower than unit length
viral DNA, integration of viral DNA into the host cell
genome should be the most likely explanation. This is further
supported by two-dimensional electrophoresis of cellular
DNA which did not reveal evidence for the presence of cir-
cular viral DNA (Figure 10).
Discussion
This report describes a new type of papillomavirus DNA
isolated from a cervical cancer biopsy. Similar to previous
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studies (Gissmann et al., 1982b; Durst et al., 1983), the DNA
was cloned by using different types of papillomavirus DNA
as probes and by applying conditions of low stringency of
hybridization (Tm - 40C). Two clones are obtained from
BamHI-restricted tumor DNA, a 6.7-kb and a 5.8-kb frag-
ment. Subsequent cloning with EcoRI revealed that the total
length of the viral DNA corresponds to 7.8 and 6.9 kb, res-
pectively. Thus, the cloned BamHI fragment used for further
analysis is representative of most but not of all specific DNA
found in this tumor. The smaller cloned molecule contains a
900-bp deletion and appears to be otherwise identical with the
DNA of the larger clone.
Identification of the cloned DNA as a new type of papillo-
mavirus DNA is based on the following characteristics
(Gissmann and Schwarz, 1984). (i) The genome size (7.8 kb)
corresponds to that of other papillomaviruses. (ii) The DNA
cross-hybridizes with DNA of other types of HPV genomes.
(iii) The genome organization corresponds to that of HPV 6
and HPV 16, as indicated by the co-linear alignment of cross-
hybridizing segments. (iv) Oligomeric circular molecules have
been demonstrated at least in one tumor. Since cross-
hybridization under conditions of high stringency with other
characterized HPV DNAs was very low, identification of this
DNA as a new type (tentatively designated as HPV 18) seems
to be justified (Coggin and zur Hausen, 1979).
The presence of this viral DNA in cervical cancer biopsies,
in one penile cancer biopsy as well as in certain cell lines deriv-
ed from cervical cancer is interesting. Up to now HPV 6
DNA has been detected in invasively growing, non-meta-
stasizing verrucous carcinomas (Buschke-Lowenstein tumors)
of penis and vulva (Gissmann et al., 1982a), HPV 10 DNA
and HPV 11 DNA in a small number of anogenital and cer-
vical cancer biopsies (Green et al., 1982; Gissmann et al.,
1983) and HPV 16 DNA in a relatively high percentage of
genital cancer biopsies (Duirst et al., 1983). In comparison
with other genital papillomavirus infections, HPV 16 and
HPV 18 reveal some remarkable features: they exhibit a sur-
prisingly specific association with malignant genital tumors.
HPV 18 thus far has been exclusively detected within malig-
nant tissue, HPV 16 is also regularly present in premalignant
'high-risk' lesions, such as Bowen's disease, Bowenoid
papulosis, severe atypia and carcinoma in situ of the cervix
(Ikenberg et al., 1983; and in preparation). By analyzing the
same tumor biopsies for HPV 16 and HPV 18 DNA, >70%
prove to be positive under stringent conditions of hybridiza-
tion (Ikenberg et al., in preparation). Since additional tumors
hybridize with probes under low stringency conditions only
(see Table I), it appears that human genital cancer is rather
regularly associated with papillomavirus infections.
Human cervical cancer cell lines containing HPV 18 DNA
are excellent tools for the further analysis for HPV 18 gene
regulation. It is particularly interesting that comparison of
HeLa cell DNA as well as of DNA from the HeLa-derived
cell line KB reveals the presence ofHPV 18-specific sequences
without major structural reorganization. Since no lines have
yet been obtained containing HPV 16 DNA, it could be con-
sidered whether the presence of HPV 18 DNA promotes an
easier establishment of lines in tissue culture.
The studies on the physical state of HPV 18 DNA indicate
its presence in tandem repeats and suggest its frequent in-
tegration within the host cell genome. The presence of cross-
reacting, but different sequences within these tumors,
however, cannot be entirely ruled out. Although many
papillomavirus infections lead to persistence of viral DNA in
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an episomal state (for review, see Pfister, 1984; Gissmann
and Schwarz, 1984), integration of papillomavirus DNA has
been suggested in other systems. BPV1 DNA has been found
integrated in one hamster tumor cell line (Breitburd et al.,
1981). Shope papillomavirus DNA has been reported to be
covalently linked to host cell DNA in rabbit tumors and
tumor cell lines (Wettstein and Stevens, 1982; McVay et al.,
1982). Recently, junction fragments between HPV 16 DNA
and host cell DNA have been cloned from a human cervical
tumor (Diirst et al., in preparation).
Materials and methods
Biopsies and extraction of DNA
Tumor biopsies were obtained from several hospitals. They were usually
stored at - 70°C. Diagnosis had been established by histological examination.
High mol. wt. DNA was extracted from tissue samples as described before
(zur Hausen et al., 1970).
Restriction enzymecleavage and blot hybridization
Restriction endonucleases were purchased from New England Biolabs or
Bethesda Research Laboratories and used according to the recommendations
made by the suppliers. Usually 10 ,g of cellular DNA were electrophoresed in
horizontal 0.4-1% agarose gels using 40 mM Tris-acetate, 2 mM EDTA
(pH 7.8) as running buffer. DNA was transferred onto nictrocellulose filters
(Schleicher and Schuell) by the method of Southern (1975).
Pre-hybridization solution contained: 5 x SSC (I x SSC is 0.15 M NaCl,
0.015 M sodium citrate), 50 mM sodium phosphate buffer (pH 6.5), 0.02%o
polyvinylpyrolidon, 0.02% bovine serum albumin, 0.02%7o Ficoll 400,
0.5 mg/ml denatured tRNA and the formamide concentration as given
below.
Hybridization was performed at 42°C in the same solution containing
20 mM sodium phosphate buffer (pH 6.5), 0.1 mg/ml tRNA and the labelled
DNA. The formamide concentration was 50%o for stringent conditions (Tm
-18°C) and 2001o for non-stringent conditions (Tm -40°C). Filters were
washed 2 x 5 min and 3 x 30 min in 0.6 x SSC, 0.1%o SDS at 63°C for str-
ingent conditions and 2 x SSC, 0.1 %0 SDS at 50°C for non-stringent condi-
tions.
Labelling of DNA
All DNAs used as probes were purified from the vector by electrophoresis and
subsequent electroelution into dialysis bags (Maniatis et al., 1982). Nick
translation (Rigby et al., 1977) to a specific activity of 108 c.p.m./yg has been
described previously (Fresen et al., 1979). 105 c.p.m./cm2 filter area were used
in most hybridization experiments.
Cloning of viral DNA
HPV DNA was cloned from a genomic library of a tumor DNA Qaboratory
code WV-341), constructed in bacteriophage vector X L47 after cleavage with
BamHI. The cloning procedure, screening of recombinants and propagation
of phages have been described before (Gissmann et al., 1982b).
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